Company
Mana Bio
Mana.bio is an AI based drug delivery startup, focusing on gene therapy
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Customers
- scientists, formulation experts, and biotech teams
- mana.bio (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 18 September 2026
About
Mana.bio is a seed stage biotech company leveraging data, machine learning and high throughput screening to design novel LNPs for targeted extrahepatic delivery of nucleic acid therapeutics.
Funding snapshot
- Total raised
- $19.5MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Seed, $19.5M2023-10-10
Funding rounds
- Seed
- $19.5M2023-10-10, Company stated
Loading relationship preview